These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 11781656)

  • 21. Tumor necrosis factor promotes human T-cell development in nonobese diabetic/severe combined immunodeficient mice.
    Samira S; Ferrand C; Peled A; Nagler A; Tovbin Y; Ben-Hur H; Taylor N; Globerson A; Lapidot T
    Stem Cells; 2004; 22(6):1085-100. PubMed ID: 15536198
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinically relevant expansion of hematopoietic stem cells with conserved function in a single-use, closed-system bioprocess.
    Madlambayan GJ; Rogers I; Purpura KA; Ito C; Yu M; Kirouac D; Casper RF; Zandstra PW
    Biol Blood Marrow Transplant; 2006 Oct; 12(10):1020-30. PubMed ID: 17084368
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Determination of engraftment potential of human cord blood stem-progenitor cells as a function of donor cell dosage and gestational age in the NOD/SCID mouse model.
    Ural SH; Sammel MD; Blakemore KJ
    Am J Obstet Gynecol; 2005 Sep; 193(3 Pt 2):990-4. PubMed ID: 16157099
    [TBL] [Abstract][Full Text] [Related]  

  • 24. NOD/SCID repopulating cells contribute only to short-term repopulation in the baboon.
    Mezquita P; Beard BC; Kiem HP
    Gene Ther; 2008 Nov; 15(21):1460-2. PubMed ID: 18563183
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular evidence of lentiviral vector-mediated gene transfer into human self-renewing, multi-potent, long-term NOD/SCID repopulating hematopoietic cells.
    Ailles L; Schmidt M; Santoni de Sio FR; Glimm H; Cavalieri S; Bruno S; Piacibello W; Von Kalle C; Naldini L
    Mol Ther; 2002 Nov; 6(5):615-26. PubMed ID: 12409260
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assay of human stem cells by repopulation of NOD/SCID mice.
    Dick JE; Bhatia M; Gan O; Kapp U; Wang JC
    Stem Cells; 1997; 15 Suppl 1():199-203; discussion 204-7. PubMed ID: 9368342
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel direct competitive repopulation assay for human hematopoietic stem cells using NOD/SCID mice.
    Tatekawa T; Ogawa H; Kawakami M; Oka Y; Yasukawa K; Sugiyama H; Kawase I; Soma T
    Cytotherapy; 2006; 8(4):390-8. PubMed ID: 16923615
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cytokine-mobilized peripheral blood CD34+Thy-1+Lin- human hematopoietic stem cells as target cells for transplantation-based gene therapy.
    Chen BP; Fraser C; Reading C; Murray L; Uchida N; Galy A; Sasaki D; Tricot G; Jagannath S; Barlogie B
    Leukemia; 1995 Oct; 9 Suppl 1():S17-25. PubMed ID: 7475307
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stem cell factor improves SCID-repopulating activity of human umbilical cord blood-derived hematopoietic stem/progenitor cells in xenotransplanted NOD/SCID mouse model.
    Zheng Y; Sun A; Han ZC
    Bone Marrow Transplant; 2005 Jan; 35(2):137-42. PubMed ID: 15543197
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibitors of histone deacetylases promote hematopoietic stem cell self-renewal.
    Young JC; Wu S; Hansteen G; Du C; Sambucetti L; Remiszewski S; O'Farrell AM; Hill B; Lavau C; Murray LJ
    Cytotherapy; 2004; 6(4):328-36. PubMed ID: 16146885
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interleukin-3 promotes proliferation and differentiation of human hematopoietic stem cells but reduces their repopulation potential in NOD/SCID mice.
    Nitsche A; Junghahn I; Thulke S; Aumann J; Radonić A; Fichtner I; Siegert W
    Stem Cells; 2003; 21(2):236-44. PubMed ID: 12634420
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of human factor IX gene in murine plasma through lentiviral vector-infected haematopoietic stem cells.
    Chen H; Yao H; Huang L; Shen Q; Jia W; Xue J
    Clin Exp Pharmacol Physiol; 2006 Dec; 33(12):1196-201. PubMed ID: 17184501
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enhanced engraftment of umbilical cord blood-derived stem cells in NOD/SCID mice by cotransplantation of a second unrelated cord blood unit.
    Nauta AJ; Kruisselbrink AB; Lurvink E; Mulder A; Claas FH; Noort WA; Willemze R; Fibbe WE
    Exp Hematol; 2005 Oct; 33(10):1249-56. PubMed ID: 16219548
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A newly discovered class of human hematopoietic cells with SCID-repopulating activity.
    Bhatia M; Bonnet D; Murdoch B; Gan OI; Dick JE
    Nat Med; 1998 Sep; 4(9):1038-45. PubMed ID: 9734397
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Design of Ad5F35 vectors for coordinated dual gene expression in candidate human hematopoietic stem cells.
    Na M; Fan X
    Exp Hematol; 2010 Jun; 38(6):446-52. PubMed ID: 20303383
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Purging of human breast cancer cells from stem cell products with an adenovirus containing p53.
    Hirai M; Kelsey LS; Vaillancourt M; Maneval DC; Watanabe T; Talmadge JE
    Cancer Gene Ther; 2000 Feb; 7(2):197-206. PubMed ID: 10770627
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Purging of contaminating breast cancer cells from hematopoietic stem cell grafts by adenoviral GAL-TEK gene therapy and magnetic antibody cell separation.
    Marini FC; Snell V; Yu Q; Zhang X; Singletary SE; Champlin R; Andreeff M
    Clin Cancer Res; 1999 Jun; 5(6):1557-68. PubMed ID: 10389945
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Who is hematopoietic stem cell: CD34+ or CD34-?
    Pei X
    Int J Hematol; 1999 Dec; 70(4):213-5. PubMed ID: 10643145
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of exogenous wt-p53 does not affect normal hematopoiesis: implications for bone marrow purging.
    Scardigli R; Bossi G; Blandino G; Crescenzi M; Soddu S; Sacchi A
    Gene Ther; 1997 Dec; 4(12):1371-8. PubMed ID: 9472561
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Third-generation, self-inactivating gp91(phox) lentivector corrects the oxidase defect in NOD/SCID mouse-repopulating peripheral blood-mobilized CD34+ cells from patients with X-linked chronic granulomatous disease.
    Roesler J; Brenner S; Bukovsky AA; Whiting-Theobald N; Dull T; Kelly M; Civin CI; Malech HL
    Blood; 2002 Dec; 100(13):4381-90. PubMed ID: 12393624
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.